Results show that NSAIDs like ibuprofen are now the prescription painkiller of choice, provided to nearly 29% of low back ...

FDA Protocol Review Completed ~ ~ Rho, Inc. Selected as Clinical Research Partner ~ SAN DIEGO, CA / ACCESS Newswire / July 16, 2025 /Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company" ...

One of the greatest revolutions in the field of pain medication was the isolation of morphine from the opium poppy in the ...

For starters, they should use Purdue Pharma’s billions to make Narcan universally accessible. State and local governments are ...

By putting a carbon atom in place of a core oxygen, chemists constructed an opioid that blocks pain with less respiratory ...

Prescription opioid abuse and its downstream effects have reached epidemic proportions in the United States. On May 26, the Food and Drug Administration (FDA) moved a step closer to providing help to ...

They say that the bill would help level the playing field by requiring insurers to treat non-opioid pain medications no differently than opioids in terms of coverage and cost to the patient.

San Antonio's newest hospital is first in Texas to offer non-opioid drug The new medication gives patients an alternative to narcotics for treatment of post-surgical pain.

Opioid therapy helps manage short-term pain caused by surgery. Learn about tapering or gradual reduction, which is a vital part of the healing process.

Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said on Tuesday, giving the drugmaker access to an experimental non-opioid pain medicine.

Eli Lilly’s acquisition of SiteOne Therapeutics comes ahead of Phase 2 testing of the startup’s lead drug candidate, which blocks the NaV1.8 sodium channel to treat pain. This target has ...

The opioid crisis has made it even more urgent to come up with novel approaches to treating suffering. Finally there’s something effective.